The global Nivolumab market size was valued at US$ 8.12 billion in 2024 and is projected to reach US$ 13.47 billion by 2030, at a CAGR of 8.8% during the forecast period 2024-2030.
United States Nivolumab market size was valued at US$ 2.65 billion in 2024 and is projected to reach US$ 4.22 billion by 2030, at a CAGR of 8.1% during the forecast period 2024-2030.
A human immunoglobulin G4 (IgG4) monoclonal antibody that blocks PD-1.
Continued growth supported by multiple approved indications across various cancer types. Strong performance in lung cancer and melanoma. Expanding use in adjuvant and neoadjuvant settings.
Report Overview
This report provides a deep insight into the global Nivolumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nivolumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nivolumab market in any manner.
Global Nivolumab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Ono Pharmaceutical
- Bristol-Myers Squibb
Market Segmentation (by Type)
- Injection 4mL
- Injection 10mL
Market Segmentation (by Application)
- Unresectable Melanoma
- Metastatic Melanoma
- Metastatic Squamous NSCLC
- Classical Hodgkin Lymphoma
- Renal Cell Carcinoma
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nivolumab Market
- Overview of the regional outlook of the Nivolumab Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nivolumab
1.2 Key Market Segments
1.2.1 Nivolumab Segment by Type
1.2.2 Nivolumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nivolumab Market Overview
2.1 Global Market Overview
2.1.1 Global Nivolumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nivolumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nivolumab Market Competitive Landscape
3.1 Global Nivolumab Sales by Manufacturers (2019-2024)
3.2 Global Nivolumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Nivolumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nivolumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nivolumab Sales Sites, Area Served, Product Type
3.6 Nivolumab Market Competitive Situation and Trends
3.6.1 Nivolumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nivolumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nivolumab Industry Chain Analysis
4.1 Nivolumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nivolumab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nivolumab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nivolumab Sales Market Share by Type (2019-2024)
6.3 Global Nivolumab Market Size Market Share by Type (2019-2024)
6.4 Global Nivolumab Price by Type (2019-2024)
7 Nivolumab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nivolumab Market Sales by Application (2019-2024)
7.3 Global Nivolumab Market Size (M USD) by Application (2019-2024)
7.4 Global Nivolumab Sales Growth Rate by Application (2019-2024)
8 Nivolumab Market Segmentation by Region
8.1 Global Nivolumab Sales by Region
8.1.1 Global Nivolumab Sales by Region
8.1.2 Global Nivolumab Sales Market Share by Region
8.2 North America
8.2.1 North America Nivolumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nivolumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nivolumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nivolumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nivolumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ono Pharmaceutical
9.1.1 Ono Pharmaceutical Nivolumab Basic Information
9.1.2 Ono Pharmaceutical Nivolumab Product Overview
9.1.3 Ono Pharmaceutical Nivolumab Product Market Performance
9.1.4 Ono Pharmaceutical Business Overview
9.1.5 Ono Pharmaceutical Nivolumab SWOT Analysis
9.1.6 Ono Pharmaceutical Recent Developments
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb Nivolumab Basic Information
9.2.2 Bristol-Myers Squibb Nivolumab Product Overview
9.2.3 Bristol-Myers Squibb Nivolumab Product Market Performance
9.2.4 Bristol-Myers Squibb Business Overview
9.2.5 Bristol-Myers Squibb Nivolumab SWOT Analysis
9.2.6 Bristol-Myers Squibb Recent Developments
10 Nivolumab Market Forecast by Region
10.1 Global Nivolumab Market Size Forecast
10.2 Global Nivolumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nivolumab Market Size Forecast by Country
10.2.3 Asia Pacific Nivolumab Market Size Forecast by Region
10.2.4 South America Nivolumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nivolumab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nivolumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nivolumab by Type (2025-2030)
11.1.2 Global Nivolumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nivolumab by Type (2025-2030)
11.2 Global Nivolumab Market Forecast by Application (2025-2030)
11.2.1 Global Nivolumab Sales (Kilotons) Forecast by Application
11.2.2 Global Nivolumab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nivolumab Market Size Comparison by Region (M USD)
Table 5. Global Nivolumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Nivolumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nivolumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nivolumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nivolumab as of 2022)
Table 10. Global Market Nivolumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nivolumab Sales Sites and Area Served
Table 12. Manufacturers Nivolumab Product Type
Table 13. Global Nivolumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nivolumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nivolumab Market Challenges
Table 22. Global Nivolumab Sales by Type (Kilotons)
Table 23. Global Nivolumab Market Size by Type (M USD)
Table 24. Global Nivolumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Nivolumab Sales Market Share by Type (2019-2024)
Table 26. Global Nivolumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Nivolumab Market Size Share by Type (2019-2024)
Table 28. Global Nivolumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Nivolumab Sales (Kilotons) by Application
Table 30. Global Nivolumab Market Size by Application
Table 31. Global Nivolumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Nivolumab Sales Market Share by Application (2019-2024)
Table 33. Global Nivolumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Nivolumab Market Share by Application (2019-2024)
Table 35. Global Nivolumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Nivolumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Nivolumab Sales Market Share by Region (2019-2024)
Table 38. North America Nivolumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Nivolumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Nivolumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Nivolumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Nivolumab Sales by Region (2019-2024) & (Kilotons)
Table 43. Ono Pharmaceutical Nivolumab Basic Information
Table 44. Ono Pharmaceutical Nivolumab Product Overview
Table 45. Ono Pharmaceutical Nivolumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ono Pharmaceutical Business Overview
Table 47. Ono Pharmaceutical Nivolumab SWOT Analysis
Table 48. Ono Pharmaceutical Recent Developments
Table 49. Bristol-Myers Squibb Nivolumab Basic Information
Table 50. Bristol-Myers Squibb Nivolumab Product Overview
Table 51. Bristol-Myers Squibb Nivolumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Nivolumab SWOT Analysis
Table 54. Bristol-Myers Squibb Recent Developments
Table 55. Global Nivolumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Nivolumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Nivolumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Nivolumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Nivolumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Nivolumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Nivolumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Nivolumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Nivolumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Nivolumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Nivolumab Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Nivolumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Nivolumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Nivolumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Nivolumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Nivolumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Nivolumab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Nivolumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nivolumab Market Size (M USD), 2019-2030
Figure 5. Global Nivolumab Market Size (M USD) (2019-2030)
Figure 6. Global Nivolumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nivolumab Market Size by Country (M USD)
Figure 11. Nivolumab Sales Share by Manufacturers in 2023
Figure 12. Global Nivolumab Revenue Share by Manufacturers in 2023
Figure 13. Nivolumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nivolumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nivolumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nivolumab Market Share by Type
Figure 18. Sales Market Share of Nivolumab by Type (2019-2024)
Figure 19. Sales Market Share of Nivolumab by Type in 2023
Figure 20. Market Size Share of Nivolumab by Type (2019-2024)
Figure 21. Market Size Market Share of Nivolumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nivolumab Market Share by Application
Figure 24. Global Nivolumab Sales Market Share by Application (2019-2024)
Figure 25. Global Nivolumab Sales Market Share by Application in 2023
Figure 26. Global Nivolumab Market Share by Application (2019-2024)
Figure 27. Global Nivolumab Market Share by Application in 2023
Figure 28. Global Nivolumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nivolumab Sales Market Share by Region (2019-2024)
Figure 30. North America Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Nivolumab Sales Market Share by Country in 2023
Figure 32. U.S. Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Nivolumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Nivolumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Nivolumab Sales Market Share by Country in 2023
Figure 37. Germany Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Nivolumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Nivolumab Sales Market Share by Region in 2023
Figure 44. China Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Nivolumab Sales and Growth Rate (Kilotons)
Figure 50. South America Nivolumab Sales Market Share by Country in 2023
Figure 51. Brazil Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Nivolumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Nivolumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Nivolumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Nivolumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Nivolumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nivolumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nivolumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Nivolumab Sales Forecast by Application (2025-2030)
Figure 66. Global Nivolumab Market Share Forecast by Application (2025-2030)
